A new DNA-based cell-transformation method could be a simpler, safer way to convert cells into beating heart cells, according to researchers at Johns Hopkins Medical Institutions. It involves no viruses and is a foolproof method to create cardiac cells that beat, they say.
Cardiac muscle cells, or cardiomyocytes, are what makes the heart beat. Scientists have been making cardiomyocytes from other cells for some time, usually by making induced pluripotent stem cells from some other cell, like skin cells or blood cells. The cells are reprogrammed into iPS cells by injecting virus particles that have been manipulated to carry genetic information.
But the viruses can cause mutations scientists don’t want, and in some cases, they cause cancer. It would be better to create new cells without involving viruses at all, but some scientists didn’t think this would be possible with heart muscle cells.Cardiomyocytes are tricky to make in the lab, developing into clumps of regular, non-beating cells if they are not developed properly. Although plenty of labs have made them, there are no standardized recipes for the nutrient and growth factor broths that help them grow into properly beating cells.
Hopkins researchers went ahead and figured that out. Johns Hopkins postdoctoral scientist Paul Burridge pored through dozens of scientific papers and worked for nearly two years to develop a foolproof heart cell recipe. It worked for 11 different stem cell lines, including embryonic stem cells and adult stem cells.
“We took the recipe for this process from a complex minestrone to a simple miso soup,” said Elias Zambidis, M.D., Ph.D., an assistant professor of oncology and pediatrics at the Johns Hopkins Institute for Cell Engineering and the Kimmel Cancer Center.
To make the virus-free mutations, scientists used plasmids, which are ring-shaped molecules of double-stranded DNA that are separate from the DNA that’s found in chromosomes. They usually occur in bacteria, and can replicate inside cells but eventually degrade.
The team worked with stem cells from umbilical cord blood and gave them a slight shock, opening a gateway for a plasmid to insert seven genes into the cells. The plasmids caused the cells to turn into iPS cells. Then, Burridge fed them his specialized, simplified broth, designed to make them into heart cells. The researchers lowered oxygen levels to simulate the hypoxic environment these cells would experience when they grow inside an embryo. Nine days later, the nonviral iPS cells became functioning cardiac cells, according to Hopkins.
Such virus-free cells could eventually be used to test new cardiac drugs, or for stem cell-derived implants to help patients whose cardiomyocytes die in a heart attack, according to Hopkins.
Watch the cells pulse in the video below.
Five amazing, clean technologies that will set us free, in this month's energy-focused issue. Also: how to build a better bomb detector, the robotic toys that are raising your children, a human catapult, the world's smallest arcade, and much more.


Online Content Director: Suzanne LaBarre | Email
Senior Editor: Paul Adams | Email
Associate Editor: Dan Nosowitz | Email
Assistant Editor: Colin Lecher | Email
Assistant Editor: Rose Pastore | Email
Contributing Writers:
Rebecca Boyle | Email
Kelsey D. Atherton | Email
Francie Diep | Email
Shaunacy Ferro | Email
The shock lets the plasmids enter the cell, but how do they get the plasmids to actually incorporate into the cell's genome? I was under the impression human cells couldn't do that.
-IMP ;) :)
@IceMetalPunk
The plasmids enter the cell but do not have to incorporate into the cell's genome in order to replicate. The plasmid it self has specific genes to begin its own replication and division every time the cell divides.
@IceMetalPunk
Think of a plasmid as a virus without a protein shell. The plasmid can be designed to carry particular genes and even target specific sites on a specific chromosome. The human DNA doesn't have the option of allowing the plasmid to bind or not, the plasmid forces the issue. They have been used for years in biomanufacturing as a vector for gene augmentation.
There is lots of research on this topic on the National Library of Medicine.
Plasmids can be used in eukaryotes iff they include enzymes (DNA pol, RNA pol) that allows for their transcription. On another note, somebody, likely DARPA, is bound to use this method for performance enhancing drugs/treatments. Also, it's always good to make uncontroversial cells from different cells (no embryos involved).